So where are all the mid-east sales?
TUCSON, AZ, Mar 25, 2013 (MARKETWIRE via COMTEX) -- CDEX Inc. (otcqb:CDEX), a leading developer of chemical detection products using patented technologies for use in healthcare, safety and security markets, today announced the company completed and shipped the 10 unit order of its ValiMed(TM) CCT drug validation system to Al-Essa Medical & Scientific Equipment Company in Safat, Kuwait ahead of schedule. The shipment completes the sale secured in December of 2012. The units will be placed in service at medical facilities throughout the region along with testing supplies for initial operation. Each unit placed requires additional service for installation and ongoing product support by CDEX for two years from the date of delivery.
"The on time completion and delivery of the 10 CCT units is a demonstration of our team's ability to execute timely. The future sales of supplies and service related to the initial transaction of these units will further our recurring sales and service revenue. The Al-Essa Group will utilize the ValiMed systems to underpin their client's efforts help assure the highest patient safety and to fight narcotics diversion in the healthcare systems they serve," stated Jeff Brumfield, chairman and chief executive officer of CDEX. "Our agreement with Al-Essa Group provides CDEX Inc. access to markets in the Middle East and could be a key foothold to build our international reach in the Middle East for our Valimed technology. We intend to showcase the Valimed G4 system to their customers once final testing is completed and the contracted units are shipped to U.S. customers during the second quarter this year."
Lies, lies, lies. Why is Brumfield still the CEO? Understandably, CDEx was in dire straights when they brought in Brumfield to spearhead the planned bankruptcy, but why is he still here?
